Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

The influence of BCG vaccine strain on mycobacteria-specific and non-specific immune responses in a prospective cohort of infants in Uganda.

Anderson EJ, Webb EL, Mawa PA, Kizza M, Lyadda N, Nampijja M, Elliott AM.

Vaccine. 2012 Mar 9;30(12):2083-9. doi: 10.1016/j.vaccine.2012.01.053. Epub 2012 Jan 31.

2.

Factors associated with tuberculosis infection, and with anti-mycobacterial immune responses, among five year olds BCG-immunised at birth in Entebbe, Uganda.

Lule SA, Mawa PA, Nkurunungi G, Nampijja M, Kizito D, Akello F, Muhangi L, Elliott AM, Webb EL.

Vaccine. 2015 Feb 4;33(6):796-804. doi: 10.1016/j.vaccine.2014.12.015. Epub 2014 Dec 19.

3.

Natural variation in immune responses to neonatal Mycobacterium bovis Bacillus Calmette-Guerin (BCG) Vaccination in a Cohort of Gambian infants.

Finan C, Ota MO, Marchant A, Newport MJ.

PLoS One. 2008;3(10):e3485. doi: 10.1371/journal.pone.0003485. Epub 2008 Oct 22.

4.

Effects of maternal and infant co-infections, and of maternal immunisation, on the infant response to BCG and tetanus immunisation.

Elliott AM, Mawa PA, Webb EL, Nampijja M, Lyadda N, Bukusuba J, Kizza M, Namujju PB, Nabulime J, Ndibazza J, Muwanga M, Whitworth JA.

Vaccine. 2010 Dec 16;29(2):247-55. doi: 10.1016/j.vaccine.2010.10.047. Epub 2010 Oct 30.

5.

A randomised controlled trial of the effects of albendazole in pregnancy on maternal responses to mycobacterial antigens and infant responses to Bacille Calmette-Guérin (BCG) immunisation [ISRCTN32849447].

Elliott AM, Namujju PB, Mawa PA, Quigley MA, Nampijja M, Nkurunziza PM, Belisle JT, Muwanga M, Whitworth JA; Mother and Baby study team.

BMC Infect Dis. 2005 Dec 21;5:115.

6.
7.

The influence of bacille Calmette-Guerin vaccine strain on the immune response against tuberculosis: a randomized trial.

Ritz N, Dutta B, Donath S, Casalaz D, Connell TG, Tebruegge M, Robins-Browne R, Hanekom WA, Britton WJ, Curtis N.

Am J Respir Crit Care Med. 2012 Jan 15;185(2):213-22. doi: 10.1164/rccm.201104-0714OC. Epub 2011 Nov 3.

PMID:
22071384
8.

Unique gene expression profiles in infants vaccinated with different strains of Mycobacterium bovis bacille Calmette-Guerin.

Wu B, Huang C, Garcia L, Ponce de Leon A, Osornio JS, Bobadilla-del-Valle M, Ferreira L, Canizales S, Small P, Kato-Maeda M, Krensky AM, Clayberger C.

Infect Immun. 2007 Jul;75(7):3658-64. Epub 2007 May 14.

9.

The immunological effect of revaccination with Bacille Calmette-Guérin vaccine at 19 months of age.

Andersen A, Roth A, Jensen KJ, Erikstrup C, Lisse IM, Whittle H, Sartono E, Yazdanbakhsh M, Aaby P, Benn CS.

Vaccine. 2013 Apr 19;31(17):2137-44. doi: 10.1016/j.vaccine.2013.02.050. Epub 2013 Mar 6.

PMID:
23474315
10.

Differential live Mycobacterium tuberculosis-, M. bovis BCG-, recombinant ESAT6-, and culture filtrate protein 10-induced immunity in tuberculosis.

Hasan Z, Jamil B, Ashraf M, Islam M, Dojki M, Irfan M, Hussain R.

Clin Vaccine Immunol. 2009 Jul;16(7):991-8. doi: 10.1128/CVI.00091-09. Epub 2009 May 13.

11.

A randomized clinical trial in adults and newborns in South Africa to compare the safety and immunogenicity of bacille Calmette-Guérin (BCG) vaccine administration via a disposable-syringe jet injector to conventional technique with needle and syringe.

Geldenhuys HD, Mearns H, Foster J, Saxon E, Kagina B, Saganic L, Jarrahian C, Tameris MD, Dintwe OB, Van Rooyen M, Luabeya KK, Hussey G, Scriba TJ, Hatherill M, Zehrung D.

Vaccine. 2015 Sep 8;33(37):4719-26. doi: 10.1016/j.vaccine.2015.03.074. Epub 2015 Apr 7.

12.

Inhibition of mycobacterial growth in vitro following primary but not secondary vaccination with Mycobacterium bovis BCG.

Fletcher HA, Tanner R, Wallis RS, Meyer J, Manjaly ZR, Harris S, Satti I, Silver RF, Hoft D, Kampmann B, Walker KB, Dockrell HM, Fruth U, Barker L, Brennan MJ, McShane H.

Clin Vaccine Immunol. 2013 Nov;20(11):1683-9. doi: 10.1128/CVI.00427-13. Epub 2013 Aug 28.

13.

Clinical and immune impact of Mycobacterium bovis BCG vaccination scarring.

Jason J, Archibald LK, Nwanyanwu OC, Kazembe PN, Chatt JA, Norton E, Dobbie H, Jarvis WR.

Infect Immun. 2002 Nov;70(11):6188-95.

14.

Enhancement of antimycobacterial Th1-cell responses by a Mycobacterium bovis BCG prime-protein boost vaccination strategy.

Lu M, Xia ZY, Bao L.

Cell Immunol. 2013 Sep-Oct;285(1-2):111-7. doi: 10.1016/j.cellimm.2013.10.001. Epub 2013 Oct 11.

PMID:
24177251
15.

The cytokine response to bacille Calmette Guérin vaccination in South India.

Das SD, Narayanan PR, Kolappan C, Colston MJ.

Int J Tuberc Lung Dis. 1998 Oct;2(10):836-43.

PMID:
9783532
16.

Broad heparin-binding haemagglutinin-specific cytokine and chemokine response in infants following Mycobacterium bovis BCG vaccination.

Smith SG, Lecher S, Blitz R, Locht C, Dockrell HM.

Eur J Immunol. 2012 Sep;42(9):2511-22. doi: 10.1002/eji.201142297. Epub 2012 Aug 1.

17.

Mycobacterium bovis BCG Vaccination Induces Divergent Proinflammatory or Regulatory T Cell Responses in Adults.

Boer MC, Prins C, van Meijgaarden KE, van Dissel JT, Ottenhoff TH, Joosten SA.

Clin Vaccine Immunol. 2015 Jul;22(7):778-88. doi: 10.1128/CVI.00162-15. Epub 2015 May 6.

18.

Delaying bacillus Calmette-Guérin vaccination from birth to 4 1/2 months of age reduces postvaccination Th1 and IL-17 responses but leads to comparable mycobacterial responses at 9 months of age.

Burl S, Adetifa UJ, Cox M, Touray E, Ota MO, Marchant A, Whittle H, McShane H, Rowland-Jones SL, Flanagan KL.

J Immunol. 2010 Aug 15;185(4):2620-8. doi: 10.4049/jimmunol.1000552. Epub 2010 Jul 19.

19.

Association of human TLR1 and TLR6 deficiency with altered immune responses to BCG vaccination in South African infants.

Randhawa AK, Shey MS, Keyser A, Peixoto B, Wells RD, de Kock M, Lerumo L, Hughes J, Hussey G, Hawkridge A, Kaplan G, Hanekom WA, Hawn TR; South African Tuberculosis Vaccine Initiative Team.

PLoS Pathog. 2011 Aug;7(8):e1002174. doi: 10.1371/journal.ppat.1002174. Epub 2011 Aug 11.

20.

Non-specific effect of Bacille Calmette-Guérin vaccine on the immune response to routine immunisations.

Ritz N, Mui M, Balloch A, Curtis N.

Vaccine. 2013 Jun 26;31(30):3098-103. doi: 10.1016/j.vaccine.2013.03.059. Epub 2013 Apr 10.

PMID:
23583897

Supplemental Content

Support Center